FDA Releases Final Guidance on Hepatitis B Risk Reduction in Blood Transfusions

The U.S. Food and Drug Administration has published its final guidance document, "Recommendations for Reducing the Risk of Transfusion-Transmitted Hepatitis B Virus." This guidance provides blood establishments with updated recommendations for testing blood and its components, including Source Plasma, to effectively minimize the risk of HBV transmission through transfusions. This aims to enhance the safety of the blood supply.